TRIM23 Antibodies

Santa Cruz Biotechnology offers a broad range of TRIM23 monoclonal antibodies for various research applications. TRIM23 monoclonal antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRIM23, a member of the tripartite motif (TRIM) family, plays a crucial role in cellular processes including protein ubiquitination, regulation of gene expression, and immune response modulation. TRIM23's involvement in various signaling pathways highlights its significance in maintaining cellular homeostasis and potential implications in disease mechanisms. Understanding TRIM23 function is essential for elucidating its role in pathologies such as cancer and autoimmune disorders. Researchers worldwide utilize TRIM23 monoclonal antibodies to advance their understanding of cellular pathways and disease mechanisms. TRIM23 monoclonal antibodies enable precise detection and analysis of protein interactions and modifications. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing potential therapeutic strategies for various diseases.